Antitumor therapy comprising distamycin derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 15, 2008
Grant Date -
Jan 8, 2004
app pub date -
Sep 21, 2001
filing date -
Oct 2, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present invention relates to an administration schedule comprising the intravenous administration of a .alpha.-halogen-acryloyl distamycin derivative, or a pharmaceutically acceptable salt thereof. The above administration allows the treatment of a variety of tumors in mammals.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully